Table 3 Baseline Characteristics of patientsa, n = 98
From: Frailty in end-stage renal disease: comparing patient, caregiver, and clinician perspectives
Demographics | |
Age (mean years ± SD) | 61 + 14 |
Male, n (%) | 57 (58) |
Caucasian, n (%) | 89 (91) |
Cause of End Stage Renal Disease, n (%) | |
Diabetes | 27 (28) |
Other | 29 (30) |
Ischemic/ Hypertension | 9 (9) |
Unknown | 7 (7) |
Glomerulonephritis | 19 (19) |
Polycystic kidney disease | 7 (7) |
Comorbid Conditions, n (%) | |
Diabetes | 46 (47) |
Coronary artery disease | 27 (28) |
Congestive heart failure | 20 (20) |
Peripheral vascular disease | 10 (10) |
Chronic lung disease | 13 (13) |
Cerebrovascular disease | 6 (6) |
Connective tissue disease | 5 (5) |
Neoplasia | 12 (12) |
Peptic ulcer disease | 9 (9) |
Laboratory | |
MDRD GFRb [median mL/min/1.73 m2 (Q1-Q3)] | 8 (6–11) |
Albumin [median g/L (Q1-Q3)] | 32 (27–34) |
Creatinine [median umol/L (Q1-Q3)] | 567 (447–764) |
Phosphate [median mmol/L (Q1-Q3)] | 1.84 (1.56–2.14) |
Hemoglobin (mean g/L ± SD) | 89 + 13 |
Dialysis Modality, n (%) | |
In center/satellite hemodialysis | 80 (82) |
Home hemodialysis | 3 (3) |
Peritoneal dialysis | 15 (15) |
Hemodialysis Access, n (%)c | |
Hemodialysis with central venous catheter | 61 (73) |
Hemodialysis with arteriovenous fistula | 22 (27) |
Other | |
BMId [median kg/m2 (Q1-Q3)] | 28 (25–32) |
Initial dialysis as inpatient, n (%)e | 33 (34) |
Late referral, n (%)f | 14 (14) |